| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |